Condensed Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Oct. 02, 2021 USD ($)	Oct. 03, 2020 USD ($)
Operating activities:
Net earnings	$ 4,782,238	$ 410,162
Adjustments:
Depreciation	546,619	525,688
Amortization	76,656	62,877
Stock-based compensation	97,652	56,122
Deferred income taxes	166,748	140,606
Distributions from affiliates	200	3,021
Equity in (earnings) losses of unconsolidated affiliates	(65,106)	14,422
Losses on assets	50,970	299,450
Changes in assets and liabilities (exclusive of acquisitions and dispositions):
Accounts receivable	(1,622,668)	37,547
Inventories	(1,976,738)	590,434
Accounts payable	343,014	15,366
Federal income taxes	262,195	18,848
Salaries, wages and related accruals	835,381	(69,235)
Other operating activities	123,202	100,283
Cash provided by operating activities	3,620,363	2,205,591
Investing activities:
Capital expenditures	(1,207,088)	(1,179,081)
Investment in and advances to affiliates	(193)	(16,542)
Disposition of plant and equipment	15,581	19,492
Acquisitions (net of cash acquired)	(1,346,608)	(20,368)
Purchase of investments	(394,141)	(401,986)
Proceeds from the sale of investments	554,898	301,249
Other investing activities	1,042	(33,536)
Cash used in investing activities	(2,376,509)	(1,330,772)
Financing activities:
Net change in short-term debt	44,831	1,334
Proceeds from long-term debt, net of discount	196,990	1,237,635
Repayment of long-term debt		(97,150)
Bond issuance related costs		(6,250)
Proceeds from exercise of stock options	143,874
Payment of tax withholdings on certain stock-based compensation	(71,494)	(17,691)
Distributions to noncontrolling interests	(120,619)	(106,193)
Cash dividends	(366,606)	(368,636)
Acquisition of treasury stock	(1,773,848)	(39,499)
Other financing activities	(7,993)	(6,983)
Cash (used in) provided by financing activities	(1,954,865)	596,567
Effect of exchange rate changes on cash	1,720	(7,790)
(Decrease) increase in cash and cash equivalents and restricted cash and cash equivalents	(709,291)	1,463,596
Cash and cash equivalents and restricted cash and cash equivalents - beginning of year	2,754,929	1,534,605
Cash and cash equivalents and restricted cash and cash equivalents - end of nine months	2,045,638	$ 2,998,201
Non-cash investing activity:
Change in accrued plant and equipment purchases	$ 14,997